The Patent Finder

Bispecific Chimeric Antigen Receptors Targeting CD20 and Bcma

Abelzeta Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2024/022317, filed Mar 29, 2024. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,311,022Bispecific Chimeric Antigen Receptors Targeting CD20 and Bcma
In force
 · High confidence
Abelzeta Inc.In force
High confidence
US 12,458,667Bispecific Chimeric Antigen Receptors Targeting CD20 and Bcma
In force
 · High confidence
Abelzeta Inc.In force
High confidence
US 12,751,973Bispecific Chimeric Antigen Receptors Targeting CD20 and Bcma
In force
 · Low confidence
Abelzeta Inc.In force
Low confidence
Application 19/188,511Bispecific Chimeric Antigen Receptors Targeting CD20 and Bcma
Pending
Not granted
Abelzeta Inc.PendingNot granted
Application 19/348,065Bispecific Chimeric Antigen Receptors Targeting CD20 and Bcma
Pending
Not granted
Abelzeta Inc.PendingNot granted
Application 19/356,548Bispecific Chimeric Antigen Receptors Targeting CD20 and Bcma
Pending
Not granted
Abelzeta Inc.PendingNot granted
Application 19/356,595Bispecific Chimeric Antigen Receptors Targeting CD20 and Bcma
Pending
Not granted
Abelzeta Inc.PendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Abelzeta Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited